Skip to main content

Urticarial Vasculitis. A Review of the Literature

  • Chapter
  • First Online:
Systemic Vasculitides: Current Status and Perspectives
  • 813 Accesses

Abstract

Urticarial vasculitis (UV) is a clinical entity characterized by the aspects of leukocytoclastic vasculitis (LCV). Since its clinical features often overlap with those of common urticaria, a lesional skin biopsy is often necessary for the diagnosis. UV may be idiopathic or caused by endogenous (tumors) or exogenous (infections) factors. UV is frequently associated to consumption of serum complement factors. In this case, UV is called hypocomplementemic urticarial vasculitis (HUV). Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a more severe form characterized by hypocomplementemia and systemic symptoms. Some patients may have UV with normal complement levels (normocomplementemic UV: NUV) and they usually have minimal or no systemic involvement. Response of UV to treatment is variable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

UV:

urticarial vasculitis

LCV:

leukocytoclastic vasculitis

HUVS:

hypocomplementemic urticarial vasculitis syndrome

SLE:

systemic lupus erythematosus

NUV/HUV:

normocomplementemic/hypocomplementemic urticarial vasculitis

CU:

chronic urticaria

COPD:

chronic obstructive pulmonary disease

ESR:

erythrocytes sedimentation rate

ANA:

antinuclear antibodies

CAPS:

cryopyrin-associated periodic syndromes

FCAS:

familial cold autoinflammatory syndrome

MWS:

Muckle-Wells syndrome

CINCA:

chronic infantile neurological cutaneous and articular syndromes

NLRP3:

NOD-like receptor protein 3

References

  1. Venzor J, Lee WL, Huston DP (2002) Urticarial vasculitis. Clin Rev Allergy Immunol 23:201–216

    Article  PubMed  Google Scholar 

  2. Davis MDP, Brewer JD (2004) Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 24:183–213

    Article  PubMed  Google Scholar 

  3. Kolkhir P, Pogorelov D, Olisova O et al (2016) Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus – a systematic review. Clin Exp Allergy 46:275–287

    Google Scholar 

  4. Schwartz HR, McDuffie FC, Black LF et al (1982) Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc 57:231–238

    CAS  PubMed  Google Scholar 

  5. Renard M, Wounters C, Proesmans W (1998) Rapidly progressive glomerulonephritis in a boy with hypocomplementemic urticarial vasculitis. Eur J Pediatr 157:243–245

    Article  CAS  PubMed  Google Scholar 

  6. Balsam L, Karim M, Miller F et al (2008) Crescentic glomerulonephritis associated with hypocomplementemic urticarial vasculitis syndrome. Am J Kidney Dis 52:1168–1173

    Article  PubMed  Google Scholar 

  7. Black AK (1999) Urticarial vasculitis. Clin Dermatol 17:565–569

    Article  CAS  PubMed  Google Scholar 

  8. Chen HJL, Bloch KJ (2001) Hypocomplementemic urticarial vasculitis, Jaccoud’s arthropathy, valvular heart disease and reversible tracheal stenosis: a surfeit of syndromes. J Rheumatol 28:383–386

    CAS  PubMed  Google Scholar 

  9. Babajanians A, Chung-Park M, Wisnieski JJ (1991) Recurrent pericarditis and cardiac tamponade in a patient with hypocomplementemic urticarial vasculitis syndrome. J Rheumatol 18:752–755

    CAS  PubMed  Google Scholar 

  10. Kervarrec T, Binois R, Bléchet C et al (2015) Hypocomplementaemic urticarial vasculitis with bullous lesions and pericardial involvement. Ann Dermatol Venereol 19:1–6

    Google Scholar 

  11. Hunt DPJ, Weil R, Nicholson AG et al (2006) Pulmonary capillaritis and its relationship to development of emphysema in hypocomplementaemic urticarial vasculitis syndrome. Sarcoidosis Vasc Diffuse Lung Dis 23:70–72

    PubMed  Google Scholar 

  12. Pujara AC, Mohammed TL (2012) Hypocomplementemic urticarial vasculitis syndrome: a rare cause of basilar panacinar emphysema. J Thorac Imaging 27:W50–W51

    Article  PubMed  Google Scholar 

  13. Jamison SC, Brierre S, Sweet J et al (2008) A case of precocious emphysema and lung cancer in a woman with a history of hypocomplementemic urticarial vasculitis. Chest 133:787–789

    Article  PubMed  Google Scholar 

  14. Sjöwall C, Hallbeck M, Sandström P (2015) Clinically suspected recurrence of gastric carcinoid proved to be hypocomplementaemic urticarial vasculitis syndrome with pulmonary involvement. Scand J Rheumatol 44:337–339

    Article  PubMed  Google Scholar 

  15. Marzano AV, Tavecchio S, Venturini M et al (2015) Urticarial vasculitis and urticarial autoinflammatory syndromes. G Ital Dermatol Venereol 150:41–50

    CAS  PubMed  Google Scholar 

  16. Lee JSS, Loh TH, Seow SC et al (2007) Prolonged urticaria with purpura: the sprectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis. J Am Accad Dermatol 56:994–1005

    Google Scholar 

  17. Filosto M, Cavallaro T, Pasolini G et al (2009) Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy. J Neurol Sci 284:179–181

    Article  PubMed  Google Scholar 

  18. Bock VL, Friedlander M, Waring D et al (2014) Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature. Australas J Dermatol 55:282–285

    Article  PubMed  Google Scholar 

  19. Moulin C, Debarbieux S, Ducastelle-Lepretre S et al (2010) Urticarial vasculitis and asymptomatic acquired C1 esterase inhibitor deficiency revealing an angioimmunoblastic T cell lymphoma. Eur J Dermatol 20:515–516

    PubMed  Google Scholar 

  20. Takao M, Hamada T, Kaji T et al (2016) Hypocomplementemic urticarial vasculitis arising in a patient with immunoglobulin G4-related disease. Int J Dermatol 55:430–433

    Google Scholar 

  21. Koudoukpo C, Jachiet M, Zini JM et al (2014) Urticarial vasculitis associated with essential thrombocythaemia progressing to myelofibrosis. Ann Dermatol Venereol 141:773–776

    Article  CAS  PubMed  Google Scholar 

  22. Zuberbier T, Maurer M (2014) Urticarial vasculitis and Schnitzler syndrome. Immunol Allergy Clin North Am 34:141–147

    Article  PubMed  Google Scholar 

  23. Makol A, Gibson LE, Michet CJ (2012) Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis. J Clin Rheumatol 18:92–95

    Article  PubMed  Google Scholar 

  24. Greenberger PA (2014) Chronic urticaria: new management options. World Allergy Organ J 7:31–36

    Article  PubMed  PubMed Central  Google Scholar 

  25. Swaminath A, Magro CM, Dwyer E (2011) Refractory urticarial vasculitis as a complication of ulcerative colitis successfully treated with rituximab. J Clin Rheumatol 17:281–283

    Article  PubMed  Google Scholar 

  26. Saigal K, Valencia IC, Cohen J et al (2003) Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab. J Am Acad Dermatol 49:S283–S285

    Article  PubMed  Google Scholar 

  27. Maurer M, Rosen K, Hsie H-J et al (2013) Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 368:924–935

    Article  CAS  PubMed  Google Scholar 

  28. Sussman G, Hébert J, Barron C et al (2014) Real-life experiences with omalizumab for the treatment of chronic urticaria. Ann Allergy Asthma Immunol 112:170–174

    Article  CAS  PubMed  Google Scholar 

  29. Kai AC, Flohr C, Grattan CE (2014) Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis. Clin Exp Dermatol 39:651–652

    Article  CAS  PubMed  Google Scholar 

  30. Ghazanfar MN, Thomsen SF (2015) Omalizumab for urticarial vasculitis: case report and review of the literature. Case Rep Dermatol Med 2015:1. doi:10.1155/2015/576893

    Article  Google Scholar 

  31. Krause K, Mahamed A, Weller K et al (2015) Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study. J Allergy Clin Immunol 132:751–754

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Triggiani .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

De Feo, G., Parente, R., Cardamone, C., Triggiani, M. (2016). Urticarial Vasculitis. A Review of the Literature. In: Dammacco, F., Ribatti, D., Vacca, A. (eds) Systemic Vasculitides: Current Status and Perspectives. Springer, Cham. https://doi.org/10.1007/978-3-319-40136-2_28

Download citation

Publish with us

Policies and ethics